urate biosynthetic process

Definition

Target type: biologicalprocess

The chemical reactions and pathways resulting in the formation of urate, the anion of uric acid, 2,6,8-trioxypurine. [GOC:mah]

Urate biosynthesis is a metabolic pathway that produces uric acid, the end product of purine metabolism in humans. This process begins with the breakdown of purine nucleotides, such as adenosine and guanosine, into hypoxanthine. Hypoxanthine is then oxidized to xanthine by the enzyme xanthine oxidase. Xanthine oxidase also catalyzes the final step in the pathway, the oxidation of xanthine to uric acid.

Urate biosynthesis is tightly regulated to maintain appropriate levels of uric acid in the blood. Elevated levels of uric acid can lead to hyperuricemia, a condition that can cause gout and kidney stones. Conversely, low levels of uric acid can lead to a deficiency in antioxidant defense.

The pathway can be broadly divided into two main stages:

1. **Purine nucleotide degradation:** This stage involves the breakdown of purine nucleotides into free purine bases. This is catalyzed by a series of enzymes, including 5'-nucleotidase, purine nucleoside phosphorylase, and adenosine deaminase.

2. **Oxidation of purine bases:** The free purine bases, such as hypoxanthine and xanthine, are then oxidized to uric acid. This is catalyzed by the enzyme xanthine oxidase, which requires molecular oxygen and produces hydrogen peroxide as a byproduct.

The specific enzymes and steps involved in urate biosynthesis can vary depending on the species. However, the overall process is conserved across most organisms.

In humans, urate biosynthesis occurs primarily in the liver. Uric acid is then filtered by the kidneys and excreted in urine. However, some uric acid is also reabsorbed in the kidneys.

The following is a detailed description of the individual steps involved in the urate biosynthesis process:

1. **Adenosine and guanosine are dephosphorylated to adenosine and guanosine:** This is catalyzed by 5'-nucleotidase.

2. **Adenosine is deaminated to inosine:** This is catalyzed by adenosine deaminase.

3. **Guanosine is deaminated to guanine:** This is catalyzed by guanine deaminase.

4. **Inosine and guanine are hydrolyzed to hypoxanthine and xanthine, respectively:** This is catalyzed by purine nucleoside phosphorylase.

5. **Hypoxanthine is oxidized to xanthine:** This is catalyzed by xanthine oxidase.

6. **Xanthine is oxidized to uric acid:** This is catalyzed by xanthine oxidase.

**Regulation of urate biosynthesis:**

Urate biosynthesis is tightly regulated to maintain appropriate levels of uric acid in the blood. The activity of xanthine oxidase, the key enzyme in the pathway, is regulated by a variety of factors, including:

* **Diet:** A high purine diet can increase the rate of urate biosynthesis.
* **Hormones:** Insulin and growth hormone can stimulate urate biosynthesis.
* **Medications:** Some medications, such as diuretics, can inhibit urate excretion and lead to hyperuricemia.

**Disorders of urate biosynthesis:**

Disorders of urate biosynthesis can lead to either hyperuricemia or hypouricemia.

* **Hyperuricemia:** This is a condition in which there is an excessive accumulation of uric acid in the blood. It can cause gout, a painful inflammatory condition that affects the joints, as well as kidney stones.
* **Hypouricemia:** This is a rare condition in which there is a deficiency of uric acid in the blood. It can lead to a deficiency in antioxidant defense.

**Clinical implications:**

Urate biosynthesis is a critical pathway for maintaining human health. Understanding the regulation and disorders of this pathway is essential for the diagnosis and treatment of various diseases, including gout, kidney stones, and hypouricemia.'"

Proteins (1)

Compounds (23)